DXCM vs EXPO · P/E 63, rev $2.50B vs P/E 28, rev $337.9M
DexCom Inc (DXCM) versus Exponent Inc (EXPO) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Exponent Inc (EXPO) is a engineering & construction company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported EXPO revenue for 2026-07-03 was $337.9M. Net income was $59.0M. EXPO currently screens at market cap $2.89B and trailing P/E 27.9.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. EXPO currently screens at market cap $2.89B and trailing P/E 27.9.
Not investment advice. Open the DXCM and EXPO stock pages for the full models.
Not investment advice.